Rezolute reports fourth quarter and full year fiscal 2024 financial results and provides business update

Fda lifts partial clinical holds on ersodetug for the treatment of congenital hi; phase 3 sunrize study to proceed in the u.s.
RZLT Ratings Summary
RZLT Quant Ranking